PharmaEssentia (TWSE: 6446) today announced its net revenues for April 2025: On a consolidated basis, revenues for April 2025 were approximately NT$1.23 billion, an increase of 3.87% from March 2025 and an increase of 83.72% from March 2024. The year-to-date consolidated revenue totaled NT$4.48 billion, an increase of 93.18%.